메뉴 건너뛰기




Volumn 52, Issue 7, 2011, Pages 4749-4756

Pharmacokinetics of pars plana intravitreal injections versus microcannula suprachoroidal injections of bevacizumab in a porcine model

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; VASCULOTROPIN; MONOCLONAL ANTIBODY;

EID: 80052385883     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-6291     Document Type: Article
Times cited : (93)

References (20)
  • 1
    • 11144354339 scopus 로고    scopus 로고
    • Prevalence of agerelated macular degeneration in the United States
    • Friedman DS, O'Colmain BJ, Munoz B, et al. Prevalence of agerelated macular degeneration in the United States. Arch Ophthalmol. 2004;122:564-572.
    • (2004) Arch Ophthalmol. , vol.122 , pp. 564-572
    • Friedman, D.S.1    O'Colmain, B.J.2    Munoz, B.3
  • 3
    • 33749451356 scopus 로고    scopus 로고
    • Ranibizumab versus verteporfin for neovascular age-related macular degeneration
    • Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1432-1444.
    • (2006) N Engl J Med. , vol.355 , pp. 1432-1444
    • Brown, D.M.1    Kaiser, P.K.2    Michels, M.3
  • 4
    • 33749445317 scopus 로고    scopus 로고
    • Ranibizumab for neovascular age-related macular degeneration
    • Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355: 1419-1431.
    • (2006) N Engl J Med. , vol.355 , pp. 1419-1431
    • Rosenfeld, P.J.1    Brown, D.M.2    Heier, J.S.3
  • 5
    • 33750305221 scopus 로고    scopus 로고
    • Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: Twenty-four-week results of an uncontrolled openlabel clinical study
    • Moshfeghi AA, Rosenfeld PJ, Puliafito CA, et al. Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: twenty-four-week results of an uncontrolled openlabel clinical study. Ophthalmology. 2006;113:2002, e2001-2012.
    • (2006) Ophthalmology. , vol.113
    • Moshfeghi, A.A.1    Rosenfeld, P.J.2    Puliafito, C.A.3
  • 6
    • 20144372969 scopus 로고    scopus 로고
    • Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study
    • Michels S, Rosenfeld PJ, Puliafito CA, Marcus EN, Venkatraman AS. Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study. Ophthalmology. 2005;112:1035-1047.
    • (2005) Ophthalmology. , vol.112 , pp. 1035-1047
    • Michels, S.1    Rosenfeld, P.J.2    Puliafito, C.A.3    Marcus, E.N.4    Venkatraman, A.S.5
  • 7
    • 33750296920 scopus 로고    scopus 로고
    • The International Intravitreal Bevacizumab Safety Survey: Using the internet to assess drug safety worldwide
    • Fung AE, Rosenfeld PJ, Reichel E. The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide. Br J Ophthalmol. 2006;90:1344-1349.
    • (2006) Br J Ophthalmol. , vol.90 , pp. 1344-1349
    • Fung, A.E.1    Rosenfeld, P.J.2    Reichel, E.3
  • 8
    • 33745386921 scopus 로고    scopus 로고
    • Intravitreal Avastin: The low cost alternative to lucentis?
    • Rosenfeld PJ. Intravitreal Avastin: the low cost alternative to lucentis? Am J Ophthalmol. 2006;142:141-143.
    • (2006) Am J Ophthalmol. , vol.142 , pp. 141-143
    • Rosenfeld, P.J.1
  • 10
    • 0029097631 scopus 로고
    • Human scleral permeability: Effects of age, cryotherapy, transscleral diode laser, and surgical thinning
    • Olsen TW, Edelhauser HF, Lim JI, Geroski DH. Human scleral permeability: effects of age, cryotherapy, transscleral diode laser, and surgical thinning. Invest Ophthalmol Vis Sci. 1995;36:1893-1903.
    • (1995) Invest Ophthalmol Vis Sci. , vol.36 , pp. 1893-1903
    • Olsen, T.W.1    Edelhauser, H.F.2    Lim, J.I.3    Geroski, D.H.4
  • 11
    • 13944264268 scopus 로고    scopus 로고
    • Permeability of retinal pigment epithelium: Effects of permeant molecular weight and lipophilicity
    • Pitkanen L, Ranta VP, Moilanen H, Urtti A. Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity. Invest Ophthalmol Vis Sci. 2005;46:641-646.
    • (2005) Invest Ophthalmol Vis Sci. , vol.46 , pp. 641-646
    • Pitkanen, L.1    Ranta, V.P.2    Moilanen, H.3    Urtti, A.4
  • 13
    • 33750086968 scopus 로고    scopus 로고
    • Cannulation of the suprachoroidal space: A novel drug delivery methodology to the posterior segment
    • Olsen TW, Feng X, Wabner K, et al. Cannulation of the suprachoroidal space: a novel drug delivery methodology to the posterior segment. Am J Ophthalmol. 2006;142:777-787.
    • (2006) Am J Ophthalmol. , vol.142 , pp. 777-787
    • Olsen, T.W.1    Feng, X.2    Wabner, K.3
  • 14
    • 65249085544 scopus 로고    scopus 로고
    • Canaloplasty: Circumferential viscodilation and tensioning of Schlemm canal using a flexible microcatheter for the treatment of open-angle glaucoma in adults: Two-year interim clinical study results
    • Lewis RA, von Wolff K, Tetz M, et al. Canaloplasty: circumferential viscodilation and tensioning of Schlemm canal using a flexible microcatheter for the treatment of open-angle glaucoma in adults: two-year interim clinical study results. J Cataract Refract Surg. 2009;35:814-824.
    • (2009) J Cataract Refract Surg. , vol.35 , pp. 814-824
    • Lewis, R.A.1    von Wolff, K.2    Tetz, M.3
  • 15
    • 78649529307 scopus 로고    scopus 로고
    • Barrier analysis of periocular drug delivery to the posterior segment
    • Ranta VP, Mannermaa E, Lummepuro K, et al. Barrier analysis of periocular drug delivery to the posterior segment. J Control Release. 2010;148:42-48
    • (2010) J Control Release , vol.148 , pp. 42-48
    • Ranta, V.P.1    Mannermaa, E.2    Lummepuro, K.3
  • 16
    • 0000510983 scopus 로고
    • The drainage of albumin from the uvea
    • Bill A. The drainage of albumin from the uvea. Exp Eye Res. 1964;3:179-187.
    • (1964) Exp Eye Res. , vol.3 , pp. 179-187
    • Bill, A.1
  • 17
    • 0001364939 scopus 로고
    • Movement of albumin and dextran through the sclera
    • Bill A. Movement of albumin and dextran through the sclera. Arch Ophthalmol. 1965;74:248-252.
    • (1965) Arch Ophthalmol. , vol.74 , pp. 248-252
    • Bill, A.1
  • 18
  • 19
    • 77953300103 scopus 로고    scopus 로고
    • Incidence and characteristics of acute intraocular inflammation after intravitreal injection of bevacizumab: A retrospective cohort study
    • Johnson D, Hollands H, Hollands S, Sharma S. Incidence and characteristics of acute intraocular inflammation after intravitreal injection of bevacizumab: a retrospective cohort study. Can J Ophthalmol. 2010;45:239-242.
    • (2010) Can J Ophthalmol. , vol.45 , pp. 239-242
    • Johnson, D.1    Hollands, H.2    Hollands, S.3    Sharma, S.4
  • 20
    • 64849085452 scopus 로고    scopus 로고
    • Characteristics of severe intraocular inflammation following intravitreal injection of bevacizumab (Avastin)
    • Georgopoulos M, Polak K, Prager F, Prunte C, Schmidt-Erfurth U. Characteristics of severe intraocular inflammation following intravitreal injection of bevacizumab (Avastin). Br J Ophthalmol. 2009;93:457-462.
    • (2009) Br J Ophthalmol. , vol.93 , pp. 457-462
    • Georgopoulos, M.1    Polak, K.2    Prager, F.3    Prunte, C.4    Schmidt-Erfurth, U.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.